We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Wins Jury Verdict Vs. Boston Scientific In Patent Suit Over Drug-Coated Stent

Law360 (March 26, 2005, 12:00 AM EST) -- Johnson & Johnson is emerging triumphantly from its patent litigation against its rivals in the highly lucrative market for drug-eluting stents, winning a second major victory this month in a jury verdict that could lead to hundreds of millions of dollars in damages.

On Thursday, a federal jury in Delaware ruled for J&J in the retrial of a four-year-old lawsuit against Boston Scientific over a patent for a drug-eluting coronary-artery stent.

The jury, in the U.S. District Court for the District of Delaware, found that a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.